Malignant complications of celiac disease: a case series and review of the literature.
Carcinoma
Case report
Celiac disease
Complication
Lymphoma
Malignancy
Journal
Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382
Informations de publication
Date de publication:
12 Dec 2022
12 Dec 2022
Historique:
received:
21
09
2022
accepted:
18
11
2022
entrez:
12
12
2022
pubmed:
13
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
Celiac disease is an immune-mediated enteropathy triggered by gluten in genetically susceptible individuals. Diagnosis is based on evaluating specific autoantibodies and histopathologic findings of duodenal biopsy specimens. The only therapy for celiac disease is a gluten-free diet. Celiac disease can be complicated by malnutrition, other autoimmune diseases, refractoriness to treatment, and gastrointestinal tumors. This article presents seven cases of malignancies in patients with celiac disease. Its objective is to raise awareness of the malignant complications of celiac disease, leading to earlier diagnosis and improved outcomes. Seven cases of malignant complications of celiac disease occurred among 190 patients followed at the Department of Internal Medicine and Gastroenterology, University Hospital Brno from 2014 to 2021. We describe these cases and the presentation, diagnostic process, course, management, and outcomes for each, along with proposed potential risk factors of malignant complications. There was one Caucasian man who was 70 years old and six Caucasian women who were 36, 46, 48, 55, 73, and 82 years old in our cohort. Of the seven cases of malignancies in our cohort, four patients were diagnosed with small bowel adenocarcinoma, one with diffuse large B-cell lymphoma, one with carcinoma of the tongue, and one with colorectal carcinoma. Malignancies occurred in 3.7% of patients followed up for celiac disease. Awareness of the malignant complications of celiac disease, risk factors, presentation, and disease course could lead to earlier diagnosis and improved outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Celiac disease is an immune-mediated enteropathy triggered by gluten in genetically susceptible individuals. Diagnosis is based on evaluating specific autoantibodies and histopathologic findings of duodenal biopsy specimens. The only therapy for celiac disease is a gluten-free diet. Celiac disease can be complicated by malnutrition, other autoimmune diseases, refractoriness to treatment, and gastrointestinal tumors. This article presents seven cases of malignancies in patients with celiac disease. Its objective is to raise awareness of the malignant complications of celiac disease, leading to earlier diagnosis and improved outcomes.
CASE PRESENTATION
METHODS
Seven cases of malignant complications of celiac disease occurred among 190 patients followed at the Department of Internal Medicine and Gastroenterology, University Hospital Brno from 2014 to 2021. We describe these cases and the presentation, diagnostic process, course, management, and outcomes for each, along with proposed potential risk factors of malignant complications. There was one Caucasian man who was 70 years old and six Caucasian women who were 36, 46, 48, 55, 73, and 82 years old in our cohort. Of the seven cases of malignancies in our cohort, four patients were diagnosed with small bowel adenocarcinoma, one with diffuse large B-cell lymphoma, one with carcinoma of the tongue, and one with colorectal carcinoma.
CONCLUSIONS
CONCLUSIONS
Malignancies occurred in 3.7% of patients followed up for celiac disease. Awareness of the malignant complications of celiac disease, risk factors, presentation, and disease course could lead to earlier diagnosis and improved outcomes.
Identifiants
pubmed: 36503568
doi: 10.1186/s13256-022-03682-3
pii: 10.1186/s13256-022-03682-3
pmc: PMC9743581
doi:
Substances chimiques
Autoantibodies
0
Types de publication
Review
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
460Subventions
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : FNBr
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : 65269705
Informations de copyright
© 2022. The Author(s).
Références
Dig Dis Sci. 1979 Sep;24(9):684-8
pubmed: 487922
Eur J Gastroenterol Hepatol. 2006 Feb;18(2):187-94
pubmed: 16394801
Mod Pathol. 2020 Jul;33(7):1398-1409
pubmed: 32066859
Gastroenterology. 1989 Aug;97(2):265-71
pubmed: 2744350
Lancet. 2001 Aug 4;358(9279):356-61
pubmed: 11502314
JAMA. 2002 Mar 20;287(11):1413-9
pubmed: 11903028
Gastroenterology. 2002 Nov;123(5):1428-35
pubmed: 12404215
United European Gastroenterol J. 2018 Dec;6(10):1485-1495
pubmed: 30574319
United European Gastroenterol J. 2019 Jun;7(5):583-613
pubmed: 31210940
J Crohns Colitis. 2017 Aug 01;11(8):942-953
pubmed: 28333239
United European Gastroenterol J. 2017 Mar;5(2):208-217
pubmed: 28344788
Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1061-8
pubmed: 23703970
QJM. 2003 May;96(5):345-53
pubmed: 12702783
Hum Pathol. 2010 Aug;41(8):1087-96
pubmed: 20334897
Best Pract Res Clin Gastroenterol. 2005 Jun;19(3):401-12
pubmed: 15925845
Clin Gastroenterol Hepatol. 2022 Feb;20(2):e111-e131
pubmed: 34033925
Am J Surg. 2010 Jun;199(6):797-803
pubmed: 20609724
Int J Mol Sci. 2020 Jun 10;21(11):
pubmed: 32532079
Cancer Res. 2004 Oct 1;64(19):7073-7
pubmed: 15466202
Dig Liver Dis. 2007 Jul;39(7):634-41
pubmed: 17531561
Eur J Gastroenterol Hepatol. 2008 Apr;20(4):297-304
pubmed: 18334873
Blood. 2012 Mar 15;119(11):2458-68
pubmed: 22271451
Medicine (Baltimore). 2015 Sep;94(38):e1612
pubmed: 26402826
Arch Pathol Lab Med. 2013 Sep;137(9):1227-31
pubmed: 23991736
Postgrad Med J. 2006 Nov;82(973):705-12
pubmed: 17099088
Clin Gastroenterol Hepatol. 2006 Mar;4(3):315-9
pubmed: 16527694
Gut. 1989 Mar;30(3):333-8
pubmed: 2707633
World J Gastroenterol. 2020 Jul 14;26(26):3780-3791
pubmed: 32774057
Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):243-51
pubmed: 9521441
Pak J Med Sci. 2021 Sep-Oct;37(5):1445-1450
pubmed: 34475928
Dig Dis Sci. 1999 Dec;44(12):2538-41
pubmed: 10630509
J Crohns Colitis. 2013 Dec;7(12):e672-7
pubmed: 23845233
Aliment Pharmacol Ther. 2017 Jan;45(2):364-372
pubmed: 27885681
Gut. 1994 Sep;35(9):1215-8
pubmed: 7959226
Gastroenterology. 2020 Nov;159(5):1686-1694.e2
pubmed: 32679218
Am J Surg Pathol. 2011 Oct;35(10):1557-69
pubmed: 21921780
Dig Liver Dis. 2018 Jan;50(1):15-19
pubmed: 29174568
Curr Hematol Malig Rep. 2011 Dec;6(4):231-40
pubmed: 21912848
Gut. 1980 Nov;21(11):1010-5
pubmed: 7450557
Gut. 2007 Oct;56(10):1373-8
pubmed: 17470479
Best Pract Res Clin Gastroenterol. 2015 Jun;29(3):451-8
pubmed: 26060109
Gut. 2005 Jan;54(1):54-9
pubmed: 15591504
Am J Otolaryngol. 2020 Nov - Dec;41(6):102653
pubmed: 32841763
Scand J Gastroenterol. 2014 May;49(5):564-8
pubmed: 24621303
Clin Gastroenterol Hepatol. 2012 Jan;10(1):30-6
pubmed: 21723236
Clin Gastroenterol Hepatol. 2010 Dec;8(12):1042-7
pubmed: 20851210
Curr Treat Options Oncol. 2008 Dec;9(4-6):388-99
pubmed: 19365735
Dig Liver Dis. 2014 Feb;46(2):97-104
pubmed: 23796552
Am J Med. 2003 Aug 15;115(3):191-5
pubmed: 12935825
Aliment Pharmacol Ther. 2010 Oct;32(8):1037-43
pubmed: 20937050
Ann Intern Med. 2013 Aug 6;159(3):169-75
pubmed: 23922062